Abha Kundi’s Insights

34 total results. Page 1 of 3.

Alerts
A Refill on Relief: FDA Extends DSCSA Exemption for Small Dispensers as Assessment Begins
News
Kundi Featured on FDA Committee Peptide Vote
News
Kundi Quoted on FDA Committee Approval of Peptide Compounds
Alerts
The (Pep)Tides Turn: FDA Panel Recommends Six of Seven for Compounding
Alerts
Reinventing the Wheel: FDA’s Hub-and-Spoke Fix for Drug Manufacturing Registration
Alerts
50 Shades of Legally Gray: FDA’s Juicy Peptide Cliffhanger
Press Release
Legal 500 Lists ArentFox Schiff in Top Tier Rankings for 2026
Alerts
Gene Editing for Human Therapies Just Got a Shortcut: What the FDA’s New Draft Guidance Means for Your Business
Alerts
Pay(or) Attention, Drug and Device Makers: FDA’s New Guidance for Talking to Health Plans
News
Brain Computer Interfaces Boot Up Multipronged Legal Issues
Alerts
AI Do: Why the FDA Wants Your Input on AI in Clinical Trials (and Why You Should Give It)
Events
Webinar: From Serial Numbers to Supply Chain Security